Panitumumab outcome by tumour location analysis
Study 181: PFS
•
Boeckx N, et al. Ann Oncol 2016;27(Suppl 6):abstract 89P (and poster).
48
44
40
36
32
28
24
20
16
12
8
4
0
0
20
40
60
80
100
Kaplan–Meier estimate
0
0
1
0
2
1
1
3
1
5
5
1
9
10
1
12
15
0
1
20
20
4
2
41
28
6
4
69
50
9
6
112
91
16
14
150
148
31
39
1:
2:
3:
4:
No. of subjects
Months
1: Pmab + FOLFIRI left side
3: Pmab + FOLFIRI right side
2: FOLFIRI left side
4: FOLFIRI right side
Median PFS, months
Pmab + FOLFIRI
FOLFIRI
HR (95% CI)
Left
8.0
5.8
0.88 (0.69‒1.12)
Right
4.8
2.4
0.75 (0.45‒1.27)
WT
RAS
